Grifoni J, Crispiatico V, Castagna A, Converti R, Ramella M, Quartarone A
Front Netw Physiol. 2025; 4:1508592.
PMID: 39911276
PMC: 11794226.
DOI: 10.3389/fnetp.2024.1508592.
Lefaucheur J, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R
Clin Neurophysiol. 2024; 164:57-99.
PMID: 38852434
PMC: 11418354.
DOI: 10.1016/j.clinph.2024.05.007.
Brin M, Blitzer A
Medicine (Baltimore). 2023; 102(S1):e32373.
PMID: 37499079
PMC: 10374190.
DOI: 10.1097/MD.0000000000032373.
Gupta N, Pandey S
Neurol Sci. 2021; 42(9):3561-3584.
PMID: 34213695
DOI: 10.1007/s10072-021-05432-7.
Desrochers P, Brunfeldt A, Sidiropoulos C, Kagerer F
Brain Sci. 2019; 9(4).
PMID: 30979073
PMC: 6523253.
DOI: 10.3390/brainsci9040079.
Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment.
Brodoehl S, Wagner F, Prell T, Klingner C, Witte O, Gunther A
Neuroimage Clin. 2019; 22:101792.
PMID: 30928809
PMC: 6444302.
DOI: 10.1016/j.nicl.2019.101792.
Central Effects of Botulinum Neurotoxin-Evidence from Human Studies.
Weise D, Weise C, Naumann M
Toxins (Basel). 2019; 11(1).
PMID: 30621330
PMC: 6356587.
DOI: 10.3390/toxins11010021.
Mechanism of action of botulinum neurotoxin: Unexpected consequences.
Hallett M
Toxicon. 2017; 147:73-76.
PMID: 28803760
PMC: 5808894.
DOI: 10.1016/j.toxicon.2017.08.011.
History of Botulinum Toxin Treatment in Movement Disorders.
Jabbari B
Tremor Other Hyperkinet Mov (N Y). 2016; 6:394.
PMID: 27917308
PMC: 5133258.
DOI: 10.7916/D81836S1.
Predicting Improvement in Writer's Cramp Symptoms following Botulinum Neurotoxin Injection Therapy.
Jackman M, Delrobaei M, Rahimi F, Atashzar S, Shahbazi M, Patel R
Tremor Other Hyperkinet Mov (N Y). 2016; 6:410.
PMID: 27625900
PMC: 5013165.
DOI: 10.7916/D82Z15Q5.
A practical approach to management of focal hand dystonia.
Pandey S
Ann Indian Acad Neurol. 2015; 18(2):146-53.
PMID: 26019409
PMC: 4445187.
DOI: 10.4103/0972-2327.156563.
A Beautician's Dystonia: Long-Lasting Effect of Botulinum Toxin.
Di Martino S, Dalise S, Lamola G, Venturi M, Rossi B, Chisari C
Case Rep Neurol Med. 2014; 2014:686181.
PMID: 25143844
PMC: 4124709.
DOI: 10.1155/2014/686181.
Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more.
Lungu C, Karp B, Alter K, Zolbrod R, Hallett M
Mov Disord. 2011; 26(4):750-3.
PMID: 21506157
PMC: 3081109.
DOI: 10.1002/mds.23504.
Evidence for the effectiveness of botulinum toxin for writer's cramp.
Dashtipour K, Pender R
J Neural Transm (Vienna). 2008; 115(4):653-6.
PMID: 18322638
DOI: 10.1007/s00702-007-0868-4.
No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
Lorenzano C, Bagnato S, Gilio F, Fabbrini G, Berardelli A
Neurotox Res. 2006; 9(2-3):141-4.
PMID: 16785111
DOI: 10.1007/BF03033932.
Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin.
Djebbari R, du Montcel S, Sangla S, Vidal J, Gallouedec G, Vidailhet M
J Neurol Neurosurg Psychiatry. 2004; 75(12):1688-91.
PMID: 15548483
PMC: 1738875.
DOI: 10.1136/jnnp.2003.032227.
Sensory representation abnormalities that parallel focal hand dystonia in a primate model.
Blake D, Byl N, Cheung S, Bedenbaugh P, Nagarajan S, Lamb M
Somatosens Mot Res. 2003; 19(4):347-57.
PMID: 12590836
PMC: 2826977.
DOI: 10.1080/0899022021000037827.
Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.
Wissel J, Kabus C, Wenzel R, Klepsch S, Schwarz U, Nebe A
J Neurol Neurosurg Psychiatry. 1996; 61(2):172-5.
PMID: 8708685
PMC: 1073991.
DOI: 10.1136/jnnp.61.2.172.
Botulinum toxin in the cerebral palsies.
Neville B
BMJ. 1994; 309(6968):1526-7.
PMID: 7819880
PMC: 2541774.
DOI: 10.1136/bmj.309.6968.1526.
Isolated idiopathic adult-onset foot dystonia and treatment with botulinum toxin.
Duarte J, Sempere A, Coria F, Claveria L, Frech F, Mataix A
J Neurol. 1995; 242(2):114-5.
PMID: 7707088
DOI: 10.1007/BF00887828.